Mitogen-Activated Protein Kinase 14, antagonists & inhibitors

All categories
Name
Mitogen-Activated Protein Kinase 14, antagonists & inhibitors
Accession Number
DBCAT002783
Description

Not Available

Drugs
DrugDrug Description
RalimetinibRalimetinib has been used in trials studying the treatment of Postmenopausal, Advanced Cancer, Adult Glioblastoma, Fallopian Tube Cancer, and Metastatic Breast Cancer, among others.
BMS-582949BMS-582949 has been investigated for the treatment of Psoriasis.
R-1487Investigated for use/treatment in rheumatoid arthritis.
Drugs & Drug Targets
DrugTargetType
R-1487Mitogen-activated protein kinase 14target